Date Filed | Type | Description |
03/21/2023 |
4
| HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 4 on Sight Sciences, Inc.
Txns:
| Granted 45,100 shares
@ $0 Granted 57,700 options to buy
@ $9.78, valued at
$564.3k
|
|
01/05/2023 |
4
| HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 4 on Sight Sciences, Inc.
Txns:
| Granted 12,000 shares
@ $0 Paid exercise price by delivering 1,192 shares
@ $12.379, valued at
$14.8k
|
|
02/11/2022 |
4
| HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 4 on Sight Sciences, Inc.
Txns:
| Granted 12,000 restricted stock units
@ $0 Granted 48,200 options to buy
@ $17.52, valued at
$844.5k
|
|
07/14/2021 |
3
| HAYDEN JEREMY B. (Chief Legal Officer) has filed a Form 3 on Sight Sciences, Inc. |
10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2019 |
4
| HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Disposed/sold 23,601 options to buy
@ $42.1, valued at
$993.6k
Granted 7,868 options to buy
@ $4.71, valued at
$37.1k
|
|
08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/03/2019 |
4
| HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Granted 12,500 shares
@ $0 |
|
01/02/2019 |
4
| HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Granted 216,449 options to buy
@ $0.7445, valued at
$161.1k
|
|
04/23/2018 |
3
| HAYDEN JEREMY B. (General Counsel) has filed a Form 3 on ENDOLOGIX INC /DE/ |
03/17/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
03/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/15/2016 |
4
| HAYDEN JEREMY B. (General Counsel & VP of BD) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns:
| Exercised (in-or-at-the-money) 1,896 rights
@ $2.55, valued at
$4.8k
Exercised (in-or-at-the-money) 948 warrants
@ $0 |
|